Frontlight ResearchEarly access
Taking people in United StatesNo phase
VALOR: Vaginal Atrophy & Long-term Observation of Recovery
Key facts
- Who runs it
- Stratpharma AG
- Where
- Birmingham, Burbank, Charleston, Dallas, Fayetteville, Laguna Hills, Lake City, Las Vegas, Los Alamitos, Memphis, Newport Beach, San Diego, Sandy Springs, and West Columbia, United StatesSee the 14 sites
- Trial code
- Status
- Recruiting
- People taking part
- 2,000 people, planned
- Started
- 30 Oct 2023
- Expected to end
- Dec 2028
- Type of study
- Interventional
- Treatments tested
- 7-0940
- Record updated
- 20 February 2026
Who can take part
- Age
- 18 years and older
- Sex
- Women only
- Healthy volunteers
- Cannot take part
The registry criteria, word for word
Show all 11 criteriaShow less
Who can take part
- Diagnosed atrophic vaginitis, lichen sclerosus, lichen simplex chronicus or lichen planus
- Continuous vulvovaginal symptoms
- Access to smartphone and tablet, laptop or computer
- Access to a valid email address
Who cannot take part
- Systemic hormonal therapy started less than 30 days before baseline
- Systemic corticosteroids ongoing treatment or used within the last 30 days before baseline
- Ongoing topical HRT or corticosteroid treatment for the indication under investigation
- Topical HRT or corticosteroid treatment used for the indication under investigation within the last 30 days before baseline
- Allergy or intolerance to ingredients or excipients of the formulation of studied products
- Unable to provide informed consent
- Patient unable to apply topical device
Where in United States
- Cahaba Dermatology Skin Health CenterBirmingham, United StatesContact: Jennifer PerryTaking people
- Velvet Clinical ResearchBurbank, United StatesContact: Monica TorresTaking people
- WR-Charleston Clinical Trials, LLCCharleston, United StatesContact: Vanessa ArmettaNot yet recruiting
- WR-Global Medical Research, LLCDallas, United StatesContact: Vicki MartinezTaking people
- WR-Carolina Institute for Clinical ResearchFayetteville, United StatesContact: Caitlyn MillerTaking people
- Orange Coast Women's Medical GroupLaguna Hills, United StatesNo longer taking part
- WR-Multi-Specialty Research AssociatesLake City, United StatesContact: Wanda NorthNot yet recruiting
- WR-Clinical Research Center of Nevada, LLCLas Vegas, United StatesContact: Melissa EllisNot yet recruiting
- WR-PRI, LLC (Los Alamitos)Los Alamitos, United StatesContact: Linette ChhinNot yet recruiting
- WR-Medical Research Center of Memphis, LLCMemphis, United StatesContact: Laurie MilesNot yet recruiting
- WR-PRI, LLC (Newport Beach)Newport Beach, United StatesContact: Diana NguyenTaking people
- WR-Women's Health Care Research, LLCSan Diego, United StatesContact: Cynthia HoNot yet recruiting
- WR-Mount Vernon Clinical Research, LLCSandy Springs, United StatesContact: Kim WilliamsNot yet recruiting
- Southern UrogynecologyWest Columbia, United StatesContact: Tina McGreadyTaking people
About the trial
What the trial wants to find out
Vulvovaginal skin conditions, namely vaginal atrophy, lichen sclerosus, lichen simplex chronicus and lichen planus affecting the female adult population will be treated with a novel gel dressing to test the short- and long-term safety and efficacy of the device.
The group in the trial
- FeasibilityTreatment being tested
Treatment: 7-0940
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Contact the study team: see the registry record → Contacts and Locations
Print a page for my doctorData and sources
- Registry record
- Listed on ClinicalTrials.gov.
- Record updated
- 20 February 2026